Best Growth Stocks to Buy for September 18th

Zacks highlighted Schneider National, National Energy Services Reunited, and Centene as Rank #1 (Strong Buy) growth stocks. Current-year consensus EPS estimates rose 14.3% for Schneider National, 4.6% for National Energy Services Reunited, and 40.9% for Centene over the past 60 days. The article is analyst-driven stock-selection commentary rather than company-specific operational news, limiting broader market impact.

Analysis

This is low-information, mechanically generated sell-side ranking content rather than a new fundamental catalyst; the estimate revisions are worth monitoring but do not independently establish durability. The highest near-term sensitivity is CNC: managed-care earnings revisions can be driven by reserving, Medicaid acuity, or utilization assumptions, each capable of reversing sharply at the next medical-cost update. A sustained rerating requires confirmation that revised earnings translate into stable medical benefit ratio guidance and cash conversion, not merely a higher consensus EPS line.

SNDR's revisions are more useful as a freight-cycle read-through than as a standalone signal. If truckload pricing and intermodal volumes are inflecting, asset-light brokers and intermodal operators with greater operating leverage—CHRW, JBHT and HUBG—could outperform SNDR after a lag; conversely, fuel-cost inflation or weak industrial demand can absorb nominal rate gains. The relevant 1-3 month catalyst is quarterly guidance on contract pricing, utilization, and intermodal margins.

NESR offers a differentiated geographic energy-services exposure, but its earnings power is tied more to Middle East/North Africa project cadence, receivable collection, and customer-capex execution than to spot oil alone. Consensus upgrades without backlog, margin, and working-capital confirmation should not command the same multiple expansion as North American service peers. QBTS has no discernible fundamental linkage to this item; exclude it from any thematic interpretation.

Key Decisions for Investors

• No event-driven trade on the ranking alone; require subsequent company guidance or independently sourced estimate dispersion data before adding risk.
• Place CNC on a long watchlist for the next earnings update: initiate only if medical-cost/medical benefit ratio guidance is maintained or improved and operating cash flow supports revised EPS. Falsifier: utilization commentary or reserve development that raises the medical-cost outlook; reassess within 1-3 months.
• Use SNDR as a freight-cycle confirmation signal rather than a primary alpha vehicle. If management confirms positive contract repricing and intermodal margin expansion, consider a 3-6 month long JBHT / short CHRW pair, sized modestly; risk is a soft industrial-production print or diesel spike reversing the relative margin thesis.
• For NESR, wait for backlog conversion, receivables, and free-cash-flow evidence at the next report before initiating. A long is justified only if revenue growth is accompanied by stable margins and working-capital discipline; deteriorating days sales outstanding is the key thesis break.